WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
Read More
Tag: Pfizer
Study finds pain gene affects success of chronic pain medicine in women
Chronic pelvic pain is a disabling condition that affects around one in four women worldwide
Read More
NeuroSense Therapeutics shares positive results of lead candidate in ALS
The neurodegenerative disease currently affects more than 200,000 people worldwide
Read More
Pfizer’s Vydura recommended by NICE for acute migraines
The treatment is the first oral GPCR receptor antagonist class recommended for NHS use
Read More
FDA approves Pfizer/BioNTech and Moderna’s adapted COVID-19 vaccines
The updated vaccines more closely target current circulating variants
Read More
Pfizer’s RSV vaccine receives EC approval to protect infants and older adults
The decision follows a recent recommendation from the European Medicines Agency’s human medicines committee
Read More
Pfizer’s maternal RSV vaccine receives FDA approval
The decision allows Abrysvo to be given to those who are 32 to 36 weeks into their pregnancy
Read More
NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks
The final draft guidance recommends rimegepant for adults who have at least four migraine attacks per month, but less than 15
Read More
NHS in Scotland receives Pfizer’s migraine treatment
Patients living with the debilitating impacts of migraine attacks will be able to access Vydura
Read More
Astellas and Pfizer reveal positive results for Xtandi
Research data follows phase 3 EMBARK trial and involves men with non-metastatic prostate cancer
Read More
Pfizer update Lyme disease vaccine candidate
Research concerning candidate VLA15 has been discontinued across certain trial sites
Read More
Pfizer and Anumana boost detection of cardiovascular disease
Partnership will support development of new algorithm and identify at risk patients
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
